Keywords: pediatric obesity, GLP-1 receptor agonists, semaglutide, adolescent weight management, pharmacotherapy, long-term safety, health equity, obesity treatment Introduction The global pediatric obesity epidemic represents one of the most pressing public health challenges of the 21st century
Conclusion Hair loss on GLP1 medications is a real concern, but it is almost always temporary telogen effluvium driven by rapid weight loss rather than permanent follicle damage
How common is B12 deficiency
Nonetheless, GLP-1GIPLani did not affect body weight, body composition, food intake or plasma levels of glucose, insulin, triglycerides or cholesterol in lean mice (Extended Data Fig
Autophagy 8 , 200212 (2012)